000 01418 a2200397 4500
005 20250513081028.0
264 0 _c19930427
008 199304s 0 0 eng d
022 _a0007-0963
024 7 _a10.1111/j.1365-2133.1993.tb15143.x
_2doi
040 _aNLM
_beng
_cNLM
100 1 _aMac Neil, S
245 0 0 _aAntiproliferative effects on keratinocytes of a range of clinically used drugs with calmodulin antagonist activity.
_h[electronic resource]
260 _bThe British journal of dermatology
_cFeb 1993
300 _a143-50 p.
_bdigital
500 _aPublication Type: Journal Article; Research Support, Non-U.S. Gov't
650 0 4 _aCalmodulin
_xantagonists & inhibitors
650 0 4 _aCell Count
_xdrug effects
650 0 4 _aCell Division
_xdrug effects
650 0 4 _aCells, Cultured
650 0 4 _aDequalinium
_xpharmacology
650 0 4 _aHumans
650 0 4 _aKeratinocytes
_xdrug effects
650 0 4 _aMiconazole
_xpharmacology
650 0 4 _aMitosis
_xdrug effects
650 0 4 _aTamoxifen
_xpharmacology
700 1 _aDawson, R A
700 1 _aCrocker, G
700 1 _aTucker, W F
700 1 _aBittiner, B
700 1 _aSingleton, J G
700 1 _aHunter, T
700 1 _aTierney, D F
773 0 _tThe British journal of dermatology
_gvol. 128
_gno. 2
_gp. 143-50
856 4 0 _uhttps://doi.org/10.1111/j.1365-2133.1993.tb15143.x
_zAvailable from publisher's website
999 _c8456718
_d8456718